Shopping Cart
- Remove All
- Your shopping cart is currently empty
(±)13-HODE cholesteryl ester, initially extracted from atherosclerotic lesions, is produced via Cu2+-catalyzed oxidation of LDL. Subsequent studies revealed that 15-LO from rabbit reticulocytes and human monocytes could metabolize cholesteryl linoleate (a major LDL component) to 13-HODE cholesteryl ester.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 μg | $245 | 35 days | |
50 μg | $465 | 35 days | |
100 μg | $878 | 35 days |
Description | (±)13-HODE cholesteryl ester, initially extracted from atherosclerotic lesions, is produced via Cu2+-catalyzed oxidation of LDL. Subsequent studies revealed that 15-LO from rabbit reticulocytes and human monocytes could metabolize cholesteryl linoleate (a major LDL component) to 13-HODE cholesteryl ester. |
Molecular Weight | 665.1 |
Formula | C45H76O3 |
Cas No. | 167354-91-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | Ethanol:PBS (1:10): <10 μg/mL DMF: >50 mg/mL DMSO: >50 mg/mL Ethanol: >50 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.